DETERIORATION OF RENAL FUNCTION DURING TREATMENT OF CHRONIC RENAL FAILURE WITH 1,25- DIHYDROXYCHOLECALCIFEROL
- 30 September 1978
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 312 (8092), 700-703
- https://doi.org/10.1016/s0140-6736(78)92702-2
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- VITAMIN D METABOLISMClinical Endocrinology, 1977
- THE EFFECT OF lα-HYDROXYVITAMIN D3IN PRE-DIALYSIS RENAL BONE DISEASEClinical Endocrinology, 1977
- BONE HISTOMORPHOMETRY IN PATIENTS WITH CHRONIC RENAL FAILURE: EFFECT OF 1α-HYDROXYVITAMIN D3Clinical Endocrinology, 1977
- THE ROLE OF VITAMIN D IN RENAL BONE DISEASEClinical Endocrinology, 1977
- 1α-Hydroxycholecalciferol. Long-Term Treatment of Patients with Uraemic OsteodystrophyNephron, 1976
- Vitamin D and the KidneyNephron, 1975
- EFFECTS OF 1,25-DIHYDROXYCHOLECALCIFEROL ON CALCIUM ABSORPTION, MUSCLE WEAKNESS, AND BONE DISEASE IN CHRONIC RENAL FAILUREThe Lancet, 1974
- FAILURE OF FORMATION OF 1,25-DIHYDROXYCHOLECALCIFEROL IN CHRONIC RENAL INSUFFICIENCYThe Lancet, 1973
- Action of 1,25-Dihydroxycholecalciferol, a Potent, Kidney-Produced Metabolite of Vitamin D3, in Uremic ManThe New England Journal of Medicine, 1972
- Unique Biosynthesis by Kidney of a Biologically Active Vitamin D MetaboliteNature, 1970